Some Australian-based companies are already assessing the risks of the 'Pelosi plan' with and contemplating whether they should delay the launch of new medicines to avoid the risk of withdrawal. …
Companies already contemplating the risk of 'Pelosi plan'
October 18, 2019 Latest NewsNews of the Day
Latest Video
New Stories
-
Parliamentary inquiry recommends reforming access arrangements for lobbyists
May 8, 2024 - - Latest News -
Island announces reallocation of US grant funding to support dengue fever trial
May 8, 2024 - - Latest News -
New TGA approvals for UCB's interleukin inhibitor
May 8, 2024 - - Latest News -
Home Affairs Minister reveals the facts on the independence of advisory committees
May 8, 2024 - - BioPharma -
AusBiotech policy leader appointed to lead BioMelbourne Network
May 8, 2024 - - BioPharma -
Momentum Clinical Research recruiting for Australian-based clinical trials
May 7, 2024 - - Australian Biotech -
TGA seeks nominations for statutory advisory committees
May 7, 2024 - - Latest News